A field-effect transistor (FET) biosensor platform that uses multichannel nanomaterial sensors with protein, antibody, and aptamer probes to electrostatically differentiate bacterial species, distinguish gram-negative from gram-positive bacteria, and quantify viable versus non-viable cells in a single test. Designed for handheld, Bluetooth-enabled operation with results in minutes.
This solution is a multiplexed biosensing platform built on field-effect transistor (FET) technology for the fast, sensitive, and quantitative detection of bacteria. By measuring changes in electrical conductance caused by bacterial binding events on functionalized sensor surfaces, the platform can differentiate bacterial species, distinguish gram-negative from gram-positive organisms, and assess cell viability from a single small sample. The technology targets applications where rapid, on-site microbial identification is critical, including clinical diagnostics, food and water safety, pharmaceutical manufacturing quality control, and environmental monitoring.
Core technology:
Validation to date: E. coli detected down to 10 CFU/mL using antibody-functionalized FET sensors.
The platform has been validated at the proof-of-concept level with E. coli detection at clinically relevant concentrations. Current and planned work focuses on extending the four-channel design to selectively detect R. pickettii in saline solutions, simultaneously reporting species presence, viability, and gram-classification. The system is being packaged into a handheld, Bluetooth-enabled prototype to support field and point-of-use testing. The technology is positioned for sponsored research collaborations, co-development partnerships, and pilot trials with industry partners interested in advancing the platform toward commercial deployment.
The University of Chicago is a private institution that brings together the power of 140 institutes and centers including an NCI-designated Comprehensive Cancer Center, a microbiome focused center, two U.S. Department of Energy National Labs (Argonne National Laboratory and Fermi National Accelerator Laboratory) and the Marine Biological Laboratory, making it a truly powerful research and development enterprise of over 15,000 faculty and research staff. UChicago is home to the Pritzker School of Molecular Engineering, launched in 2011 as the first and only engineering school in the U.S. focused entirely on molecular engineering with one of the major focused areas in immunoengineering, and a core partner of the Chan Zuckerberg (CZ) Biohub - Chicago. Researchers at UChicago have pioneered breakthroughs including discovering the link between cancer and genetics, establishing revolutionary theories of economics, and developing tools to enhance urban schooling. UChicago researchers are at the forefront of fields ranging from quantum computing, data science and artificial intelligence, to the modeling and synthesis of advanced materials, to oncology and neuroscience.